Pradeep Das Selected Research

Neoplasms (Cancer)

9/2013	Effectiveness of miltefosine treatment in targeting anti-leishmanial HO-1/Nrf-2-mediated oxidative responses in visceral leishmaniasis patients.
9/2012	Quantifying the structural requirements for designing newer FLT3 inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pradeep Das Research Topics

Disease

95	Visceral Leishmaniasis (Kala Azar) 05/2024 - 07/2007
37	Infections 01/2024 - 11/2003
31	Leishmaniasis 05/2024 - 05/2007
3	Disease Progression 12/2023 - 03/2011
3	Tuberculosis (Tuberculoses) 10/2022 - 08/2014
3	Coinfection 01/2022 - 08/2014
3	Diarrhea 12/2020 - 06/2009
3	Necrosis 01/2020 - 10/2012
3	Malaria 01/2019 - 06/2015
2	Bites and Stings (Sting) 01/2021 - 01/2019
2	Gastroenteritis 12/2020 - 10/2020
2	Neglected Diseases 01/2019 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 10/2018 - 12/2017
2	Body Weight (Weight, Body) 11/2017 - 10/2015
2	Anemia 01/2014 - 11/2013
2	Neoplasms (Cancer) 09/2013 - 09/2012
2	Amebiasis (Amoebiasis) 07/2005 - 02/2004
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Uveitis 01/2020
1	Anterior Uveitis 01/2020
1	Human Influenza (Influenza) 05/2019
1	Virus Diseases (Viral Diseases) 05/2019
1	Acidosis 01/2019
1	Parasitemia 10/2018

Drug/Important Bio-Agent (IBA)

16	miltefosine (Impavido)IBA 05/2024 - 03/2009
13	AntigensIBA 01/2024 - 01/2014
12	liposomal amphotericin B FDA Link 10/2022 - 04/2012
11	CytokinesIBA 01/2024 - 07/2012
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2008
10	VaccinesIBA 11/2023 - 04/2014
9	Interleukin-10 (Interleukin 10)IBA 01/2024 - 06/2009
8	DDTIBA 12/2019 - 10/2010
7	Amphotericin B (Amphotericin)FDA LinkGeneric 06/2017 - 02/2009
6	EpitopesIBA 01/2022 - 01/2017
6	InsecticidesIBA 08/2019 - 10/2010
6	Interleukin-12 (IL 12)IBA 11/2018 - 05/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2017
5	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2019 - 04/2011
5	EnzymesIBA 01/2018 - 07/2012
4	AntimonyIBA 02/2022 - 02/2009
4	Peptides (Polypeptides)IBA 01/2022 - 01/2017
4	trypanothioneIBA 01/2018 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2022 - 05/2007
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2022 - 01/2015
3	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 06/2009
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2014
3	Protein Disulfide-IsomerasesIBA 01/2017 - 05/2014
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017 - 04/2014
2	CalciumIBA 12/2023 - 04/2013
2	Leishmaniasis VaccinesIBA 11/2023 - 01/2021
2	AntibodiesIBA 11/2023 - 10/2018
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2019
2	Nucleic AcidsIBA 01/2022 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 10/2021 - 06/2017
2	Oxidants (Oxidizing Agents)IBA 10/2021 - 12/2016
2	Rotavirus VaccinesIBA 12/2020 - 10/2020
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 01/2019
2	Cysteine Proteases (Cysteine Protease)IBA 10/2020 - 11/2012
2	Adenosine DeaminaseIBA 01/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	ArsenicIBA 01/2019 - 10/2016
2	ArginaseIBA 11/2018 - 01/2017
2	CaspasesIBA 10/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 10/2018 - 05/2010
2	Attenuated VaccinesIBA 01/2018 - 01/2016
2	A-Form DNA (A-DNA)IBA 01/2018 - 04/2014
2	tryparedoxinIBA 01/2018 - 02/2016
2	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 03/2016
2	Purine NucleosidesIBA 01/2017 - 03/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2015
2	ZincIBA 01/2017 - 04/2013
2	Oxygen (Dioxygen)IBA 03/2016 - 02/2004
2	Sulfhydryl Compounds (Thiols)IBA 02/2016 - 01/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015 - 10/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 06/2009
2	Pentamidine (NebuPent)FDA LinkGeneric 04/2012 - 02/2009
2	CholesterolIBA 12/2010 - 06/2009
1	HLA-A*02:01 antigenIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 10/2021
1	Triclosan (pHisoHex)FDA Link 10/2021
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 10/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2021
1	mevalonate kinaseIBA 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	Peptide Elongation Factors (Elongation Factor)IBA 10/2020
1	Viral RNAIBA 05/2019
1	Antiviral Agents (Antivirals)IBA 05/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019
1	Drinking WaterIBA 01/2019
1	Acid Sensing Ion ChannelsIBA 01/2019
1	SYBR Green IIBA 11/2018
1	Cyclin AIBA 11/2018
1	ribosomal protein S12IBA 10/2018

Therapy/Procedure

14	Therapeutics 10/2022 - 06/2009
3	Immunomodulation 02/2022 - 01/2014
3	Aftercare (After-Treatment) 01/2020 - 04/2012
2	Drug Therapy (Chemotherapy) 01/2016 - 01/2014
1	Intradermal Injections 01/2021